Price: $37.97
(as of Jan 07,2025 10:27:24 UTC – Details)
What is NAD+ Resveratrol?
NAD+ Resveratrol is a combination of two powerful compounds: NAD+ (Nicotinamide Adenine Dinucleotide) and Resveratrol. NAD+ is a coenzyme found in all living cells, essential for energy production, DNA repair, and maintaining cellular health. As we age, NAD+ levels naturally decline, which can impact metabolism and overall health. Resveratrol, a polyphenol found in grapes, berries, and red wine, has antioxidant properties and is thought to support heart health, longevity, and fight inflammation. Together, these compounds are believed to enhance mitochondrial function, promote healthy aging, and support cellular repair and regeneration.
How to use:
Take 2 capsules per day, 60 day supply
Can be taken at any time of the day – before, during or after meals
Caution:
Keep out of reach of children. Always speak to your physician before using any dietary supplement. Do not use if tamper-proof seal is broken or missing.
Package Dimensions : 3.98 x 2.24 x 2.24 inches; 4.16 ounces
Date First Available : December 19, 2024
Manufacturer : VITAMINFATE
ASIN : B0DQYTG92X
Anti-Aging NAD+ Supplement: Our formula featuring NAD+ and Resveratrol is designed to combat the signs of aging by promoting cellular repair, enhancing energy levels, and strengthening the immune system
Energy Formula: Elevate your energy and vitality with this supplement that boosts NAD+ levels, potentially leading to improved overall performance and well-being
Metabolic Enhancement: NAD+ is essential for metabolic processes. This nad supplement can help accelerate your metabolic rate, thereby amplifying the body’s energy production capabilities
Antioxidant Supports: NAD+ supplementation not only raises NAD+ levels but also supports mitochondrial, metabolic, and cognitive health, thereby reinforcing the body’s antioxidant defenses
Suggested Use: For best results, consume 2 capsules daily, offering a 60-day supply to steadfastly support your health objectives
Reviews
There are no reviews yet.